• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Letter to the Editor regarding Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.

作者信息

Manning Evan, Ho Michael, Sandhu Amneet

机构信息

Internal Medicine Residency Training Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Deparment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

出版信息

Clin Cardiol. 2023 Nov;46(11):1459-1460. doi: 10.1002/clc.24122. Epub 2023 Aug 15.

DOI:10.1002/clc.24122
PMID:37583247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10642318/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d337/10642318/e9d2fa9123d5/CLC-46-1459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d337/10642318/e9d2fa9123d5/CLC-46-1459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d337/10642318/e9d2fa9123d5/CLC-46-1459-g001.jpg

相似文献

1
Response to Letter to the Editor regarding Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.对致编辑信的回复，该信涉及新诊断房颤患者口服抗凝药处方状态的相关因素。
Clin Cardiol. 2023 Nov;46(11):1459-1460. doi: 10.1002/clc.24122. Epub 2023 Aug 15.
2
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores.心房颤动患者的个体化口服抗凝处方：临床风险预测评分的应用与误用
Eur J Prev Cardiol. 2020 May;27(7):726-728. doi: 10.1177/2047487319877469. Epub 2019 Oct 4.
3
Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.与新诊断为心房颤动的患者口服抗凝药物处方状况相关的因素。
Clin Cardiol. 2023 Aug;46(8):937-941. doi: 10.1002/clc.24077. Epub 2023 Jul 4.
4
Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.法国非瓣膜性心房颤动患者中阿哌沙班预防卒中和全身性栓塞：PAROS 横断面研究的原理和设计。
Arch Cardiovasc Dis. 2018 May;111(5):349-356. doi: 10.1016/j.acvd.2017.07.005. Epub 2017 Nov 27.
5
Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.急诊医师对房颤患者抗凝治疗启动的态度。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105474. doi: 10.1016/j.jstrokecerebrovasdis.2020.105474. Epub 2020 Nov 23.
6
Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding.考虑到脑梗死和出血风险的老年房颤患者的抗凝治疗趋势。
Sci Rep. 2023 Jan 5;13(1):192. doi: 10.1038/s41598-022-26741-7.
7
The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF).在老年心房颤动患者中，预后分层对开具抗凝药物的作用：一项多中心、观察性、前瞻性的欧洲研究（EUROSAF）。
Ann Med. 2022 Dec;54(1):2411-2419. doi: 10.1080/07853890.2022.2117407.
8
The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department.急诊科房颤患者的口服抗凝剂应用。
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104599. doi: 10.1016/j.jstrokecerebrovasdis.2019.104599. Epub 2020 Jan 27.
9
Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.非瓣膜性心房颤动引起的心源性脑栓塞患者中，专科医生与非专科医生之间的口服抗凝药物处方差异。
Heart Vessels. 2022 May;37(5):867-874. doi: 10.1007/s00380-021-01984-y. Epub 2021 Nov 19.
10
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.医疗机构类型、抗凝药物处方模式与房颤患者的卒中风险
J Am Heart Assoc. 2018 Mar 10;7(6):e007943. doi: 10.1161/JAHA.117.007943.

本文引用的文献

1
Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.与新诊断为心房颤动的患者口服抗凝药物处方状况相关的因素。
Clin Cardiol. 2023 Aug;46(8):937-941. doi: 10.1002/clc.24077. Epub 2023 Jul 4.
2
Gender and Socioeconomic Inequality in the Prescription of Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation in Primary Care in Catalonia (Fantas-TIC Study).性别和社会经济不平等在非瓣膜性心房颤动患者在初级保健中的直接口服抗凝剂处方（Fantas-TIC 研究）在加泰罗尼亚。
Int J Environ Res Public Health. 2021 Oct 19;18(20):10993. doi: 10.3390/ijerph182010993.
3
Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs.
使用 Watchman 装置行左心耳封堵术可降低房颤管理费用。
Clin Res Cardiol. 2022 Jan;111(1):105-113. doi: 10.1007/s00392-021-01943-7. Epub 2021 Oct 15.
4
Population Trends in All-Cause Mortality and Cause Specific-Death With Incident Atrial Fibrillation.人口死因死亡率与特定病因死亡率趋势：与新发心房颤动的关系。
J Am Heart Assoc. 2020 Oct 20;9(19):e016810. doi: 10.1161/JAHA.120.016810. Epub 2020 Sep 13.
5
Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.韩国非瓣膜性心房颤动患者中口服抗凝剂的应用。
Int J Clin Pharm. 2019 Dec;41(6):1434-1441. doi: 10.1007/s11096-019-00901-8. Epub 2019 Sep 14.
6
Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.退伍军人事务部非瓣膜性心房颤动的抗凝药物处方。
J Am Heart Assoc. 2019 Sep 3;8(17):e012646. doi: 10.1161/JAHA.119.012646. Epub 2019 Aug 23.
7
Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.口服抗凝治疗处方在具有不同卒中风险谱的房颤患者中的应用：来自 NCDR PINNACLE 注册研究的启示。
JAMA Cardiol. 2016 Apr 1;1(1):55-62. doi: 10.1001/jamacardio.2015.0374.
8
Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical inpatients with atrial fibrillation.老年房颤内科住院患者的健康状况、老年综合征及口服抗凝治疗处方
Geriatr Gerontol Int. 2017 Mar;17(3):416-423. doi: 10.1111/ggi.12730. Epub 2016 Jan 28.
9
Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.经皮左心耳封堵术与华法林治疗心房颤动的随机临床试验。
JAMA. 2014 Nov 19;312(19):1988-98. doi: 10.1001/jama.2014.15192.
10
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告
Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28.